Orkambi
Chemical Name | lumacaftor/ivacaftor |
Dosage Form | Tablet (oral; lumacaftor mg/ivacaftor mg: 100 mg/125 mg, 200 mg/125 mg); granules (oral; lumacaftor mg/ivacaftor mg: 100 mg/125 mg, 150 mg/188 mg) |
Drug Class | CFTR potentiators |
System | Respiratory |
Company | Vertex Pharms Inc |
Approval Year | 2015 |
Indication
- For the treatment of cystic fibrosis (CF) in patients age 2 years and older who are homozygous for the F508del mutation in the CFTR gene.
Last updated on 10/29/2020